Zhejiang Huakang Pharmaceutical Co., Ltd.SSE: 605077

(605077)"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes

· Issued by Zhejiang Huakang Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 605077 · · 3 pages · Chinese

Summary by 6ix AI

Zhejiang Huakang Pharmaceutical Co., Ltd. has announced the results of the conversion of its convertible bonds and the resulting changes in share capital. The report details the cumulative conversion of bonds into shares and the number of shares that have changed as a result of this process. It also outlines the total amount of convertible bonds that remain unconverted as of the reporting date.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/605077zhejiang-huakang-pharmaceutical-co-ltdannouncement-on-conversion-results-of-convertible-bonds-and-share-changes

Release

Announcement on Conversion Results of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Zhejiang Huakang Pharmaceutical

All Zhejiang Huakang Pharmaceutical news releases